Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "Restriction map" patented technology

A restriction map is a map of known restriction sites within a sequence of DNA. Restriction mapping requires the use of restriction enzymes. In molecular biology, restriction maps are used as a reference to engineer plasmids or other relatively short pieces of DNA, and sometimes for longer genomic DNA. There are other ways of mapping features on DNA for longer length DNA molecules, such as mapping by transduction.

System and process for validating, aligning and reordering one or more genetic sequence maps using at least one ordered restriction map

A method and system are provided for comparing ordered segments of a first DNA restriction map with ordered segments of a second DNA restriction map to determine a level of accuracy the first DNA map and / or the second DNA map. In particular, the first and second DNA maps can be received (the first DNA map corresponding to a sequence DNA map, and the second DNA map corresponding to a genomic consensus DNA map as provided in an optical DNA map). Then, the accuracy of the first DNA map and / or the second DNA map is validated based on information associated with the first and second DNA maps. In addition, a method and system are provided for aligning a plurality of DNA sequences with a ordered DNA restriction map. The DNA sequences and the DNA map are received (the DNA sequences being fragments of a genome and the DNA map corresponding to a genomic consensus DNA map which relates to an optical ordered DNA map). Then, a level of accuracy of the DNA sequences and the DNA map is obtained based on information associated with the DNA sequences and the DNA map by means of the method and system described above. The locations of the DNA map at which the DNA sequences are capable of being associated with particular segments of the DNA map are located. Furthermore, it is possible to obtain locations of the DNA map (without the validation) by locating an optimal one of the locations for each of the DNA sequences for each of the locations.
Owner:WISCONSIN ALUMNI RES FOUND

System and process for validating, aligning and reordering one or more genetic sequence maps using at least one ordered restriction map

A method and system are provided for comparing ordered segments of a first DNA restriction map with ordered segments of a second DNA restriction map to determine a level of accuracy the first DNA map and/or the second DNA map. In particular, the first and second DNA maps can be received (the first DNA map corresponding to a sequence DNA map, and the second DNA map corresponding to a genomic consensus DNA map as provided in an optical DNA map). Then, the accuracy of the first DNA map and/or the second DNA map is validated based on information associated with the first and second DNA maps. In addition, a method and system are provided for aligning a plurality of DNA sequences with a ordered DNA restriction map. The DNA sequences and the DNA map are received (the DNA sequences being fragments of a genome and the DNA map corresponding to a genomic consensus DNA map which relates to an optical ordered DNA map). Then, a level of accuracy of the DNA sequences and the DNA map is obtained based on information associated with the DNA sequences and the DNA map by means of the method and system described above. The locations of the DNA map at which the DNA sequences are capable of being associated with particular segments of the DNA map are located. Furthermore, it is possible to obtain locations of the DNA map (without the validation) by locating an optimal one of the locations for each of the DNA sequences for each of the locations.
Owner:WISCONSIN ALUMNI RES FOUND

Method for rapid identification of liriomya huidobresis blanchard similar species by using PCR-RFLP technology

The invention discloses a method which can rapidly identify liriomyza approximate species by PCR-RFLP technology, which belongs to the insect species identification technical field. The method includes: (1) the DNA extraction of liriomyza trifolii, Americanliriomyza and South American liriomyza samples; (2) obtaining DNA sequence of 805bp by the PCR reaction of COII gene according to insect COII gene universal primers; (3) obtaining the COII sequence respectively through the clone, the transformation and the sequencing; (4) the selection of restriction endonuclease DraI; (5) the distinction of three approximate liriomyzas through a restriction map. The invention has the characteristics of accuracy, stability, fastness, cheapness, etc. And the invention can be applied in related departments of quarantine inspection, forecast, prevention, etc. to realize the rapid detection on the three approximate liriomyzas.
Owner:CHINA JILIANG UNIV

Method for detecting polymorphism of human gastric cancer susceptible genes IL17A rs3748067 by aid of ApoI

The invention discloses a method for detecting the polymorphism of human gastric cancer susceptible genes IL17A rs3748067 by the aid of ApoI. The method includes amplifying target DNA (deoxyribonucleic acid) fragments by means of polymerase chain reaction; digesting to-be-detected DNA fragments by the aid of restriction incision enzymes; identifying and cutting specific sequences by the aid of the restriction incision enzymes; carrying out electrophoresis on digested products; analyzing cleavage sites of the sequences of the fragments by the aid of restriction maps; comparing the difference of gene sequences from different sources by the aid of the diversity of the fragments. The method has the advantages that briefly speaking, the corresponding target fragments are amplified by means of PCR (polymerase chain reaction) at first, then digestion reaction is carried out by the aid of the restriction incision enzymes, the restriction maps are observed and compared after electrophoresis is carried out, and accordingly the difference between the sequences can be analyzed; the method is good in repeatability, easy to implement and low in cost, and digestion results are easy to identify; the method and detection reagent kits which are easy to implement, low in cost and wide in application range can be provided for detecting the polymorphism of the human gastric cancer susceptible genes IL17A rs3748067.
Owner:ZHENGZHOU UNIV

Method for identifying polymorphism of human breast cancer genes RAD51 rs7180135 by aid of BccI

The invention discloses a method for identifying the polymorphism of human breast cancer genes RAD51 rs7180135 by the aid of BccI. The method is implemented by the aid of polymerase chain reaction-restriction fragment length polymorphism processes, and includes amplifying target DNA (deoxyribonucleic acid) fragments by means of polymerase chain reaction; digesting to-be-detected DNA fragments by the aid of restriction incision enzymes; identifying and cutting specific sequences by the aid of the restriction incision enzymes; carrying out electrophoresis on digested products; analyzing specific cleavage sites of the sequences of the fragments by the aid of restriction maps; comparing the differences of the gene sequences from different sources by the aid of the diversity of the fragments. The method has the advantages that briefly speaking, the corresponding target fragments are amplified by means of PCR (polymerase chain reaction) at first, then digestion reaction is carried out by the aid of the restriction incision enzymes, the restriction maps are observed and compared after electrophoresis is carried out, and accordingly the difference between the sequences can be analyzed; the method is good in repeatability, easy to implement and low in cost, and digestion results are easy to identify; the method and detection reagent kits which are easy to implement, low in cost and wide in application range can be provided for detecting the polymorphism of the human breast cancer susceptible genes RAD51 rs7180135.
Owner:ZHENGZHOU UNIV

Method and kit for detecting CYP2C19*2 polymorphic site genotype

The invention discloses a method and kit for detecting the CYP2C19*2 polymorphic site genotype. During the process of detecting CYP2C19*2 polymorphic site genotype, a specific internal quality control mechanism is introduced, namely, an internal control enzyme cutting site is introduced into a PCR product; according to the restriction map, the incomplete enzyme cutting can be identified; moreover, under the situation that the enzyme cutting is incomplete and part of enzyme cutting strips is obscure, the genotype can still be judged accurately, and the accuracy of detection results is greatly improved.
Owner:GUANGDONG PHARMA UNIV

Molecular genetic marker for slaughter performance of Bian chicken and application thereof

The invention relates to the field of poultry breeding, specifically to a molecular genetic marker for slaughter performance of Bian chicken and application thereof. The invention discloses application of a myostatin (MSTN) gene as the molecular genetic marker for slaughter performance of Bian chicken. A method for improving slaughter performance of Bian chicken by using the MSTN gene comprises the following concrete steps: carrying out amplification so as to obtain a target fragment of the MSTN gene (162 bp), subjecting the target fragment to digestion by restriction enzyme BbvI, carrying out gel electrophoresis, then carrying out silver staining for color development so as to obtain a restriction map of DNA and based on the quantity and the sizes of stripes in the restriction map, judging slaughter performance of to-be-tested samples and selecting samples according with breeding purposes, wherein samples with only 162 bp stripes are homozygous samples with high slaughter performance and samples with only 127 bp stripes are homozygous samples with low slaughter performance. The method provided by the invention is simple and fast, is not affected by an external environment and can be used for molecular genetic marking of slaughter performance of Bian chicken and for marker assisted selection.
Owner:YANGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products